DrConstance Bailey
Senior Lecturer
Faculty of Science
Research projects & supervision summary
- Development of cell free expression tools for prototypying pathway design
- Genetic tool development for heterologous expression in Actinobacteria and Myxobacteria
- Polyketide synthase and non-ribosomal peptide synthetase enzymology
- Directed evolution for late stage functionalization of natural product scaffolds
- Heterologous expression of biosynthetic pathways
- Discovery and development of natural product leads that target the cell surface of antimicrobially resistant pathogens
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONA cell free strategy for developing biocatalytic transformations from RiPPs.
- RESEARCH-BASED DEGREE SUPERVISIONbuilding a cell free expression platform based on Myxobacteria Sorangium cellulosum
- RESEARCH-BASED DEGREE SUPERVISIONCAPTURE Biosynthetic Gene Clusters from Actinokineospora sp. and Research on Natural Products
- RESEARCH-BASED DEGREE SUPERVISIONDeveloping a biocatalytic toolkit to expand the chemical diversity of bioactive molecules
- RESEARCH-BASED DEGREE SUPERVISIONDeveloping molecular cloning tool for Streptomyces based on IS110 transposable element
- RESEARCH-BASED DEGREE SUPERVISIONDevelopment of a Novel Inhibitor for FANCM-RMI
- RESEARCH-BASED DEGREE SUPERVISIONDevelopment of a Pseudomonas putida cell-free protein synthesis system for PKS or NRPS expression with Genome Mining.
- RESEARCH-BASED DEGREE SUPERVISIONEngineering flavin dependent tryptophan halogenases to expand antimicrobial compound diversity
- RESEARCH-BASED DEGREE SUPERVISIONEnzymatic Characterization of Biocatalytically Relevant Enzymes
- RESEARCH-BASED DEGREE SUPERVISIONHeterologous expression of lasso peptides in Streptomyces albus from actinomycetes isolated from Australian soil.
- RESEARCH-BASED DEGREE SUPERVISIONPeptide-based modulation of MLH1-dependent mismatch repair to improve prime editing for bone marrow failure syndrome
- RESEARCH-BASED DEGREE SUPERVISIONUltra-high-throughput maturase engineering to unlock semi-synthetic darobactins for multidrug-resistant Gram-negative bacteria